Inventor · disambiguated record
Didier Leturcq
Also filed as: LETURCQ DIDIER · LETURCQ DIDIER J
14 granted patents·2 pending applications·178 citations·filing 1994–2012
93Inventor score
Files withSCRIPPS RESEARCH INST9ORTHO MCNEIL PHARM INC2CAI ZELING1JANSSEN PHARMACEUTICA NV1LETURCQ DIDIER J1
Top patents by PatentIndex Score
16 records- 0193US6790662B1Method of isolating CD8+ cells, and related hybridoma cells antibodies and polypeptidesORTHO MCNEIL PHARM INC·Filed 2000·Granted Sep 14, 2004·41 cites·5 claims
- 0288US8124408B2Preparation of inactivated artificial antigen presenting cells and their use in cell therapiesCAI ZELING·Filed 2007·Granted Feb 28, 2012·15 cites·24 claims
- 0388US6828150B2Antigen presenting system and methods for activation of T-cellsSCRIPPS RESEARCH INST·Filed 2002·Granted Dec 7, 2004·11 cites·10 claims
- 0481US8357533B2Preparation of inactivated artificial antigen presenting cells and their use in cell therapiesJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jan 22, 2013·5 cites·11 claims
- 0579US6444206B1Methods and compositions for inhibiting CD14 mediated cell activationSCRIPPS RESEARCH INST·Filed 1998·Granted Sep 3, 2002·36 cites·3 claims
- 0679US5820858AMethods and compositions for inhibiting CD14 mediated cell activationSCRIPPS RESEARCH INST·Filed 1994·Granted Oct 13, 1998·28 cites·59 claims
- 0778US7326569B2Hybrid cells producing monoclonal anti-CD14 antibodiesSCRIPPS RESEARCH INST·Filed 2002·Granted Feb 5, 2008·9 cites·3 claims
- 0875US7247474B2Monoclonal antibody which specifically binds to but does not activate the CD8+ cellsORTHO MCNEIL PHARM INC·Filed 2004·Granted Jul 24, 2007·2 cites·2 claims
- 0975US6461867B1Synthetic antigen presenting matrixSCRIPPS RESEARCH INST·Filed 1996·Granted Oct 8, 2002·22 cites·3 claims
- 1074US9222070B2Cell therapy method for the treatment of tumorsLETURCQ DIDIER J·Filed 2007·Granted Dec 29, 2015·1 cites·8 claims
- 1167US2005152916A1Antigen presenting system and methods for activation of T-cellsSCRIPPS RESEARCH INST·Filed 2004·Application pending·0 cites
- 1261US9222071B2Cell therapy method for the treatment of tumorsMORIARTY ANN·Filed 2008·Granted Dec 29, 2015·0 cites·11 claims
- 1356US6884417B2Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their useSCRIPPS RESEARCH INST·Filed 2001·Granted Apr 26, 2005·0 cites·7 claims
- 1455US2004071671A1Cell therapy method for the treatment of tumorsFiled 2002·Application pending·0 cites
- 1547US5753504AMonoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their useSCRIPPS RESEARCH INST·Filed 1996·Granted May 19, 1998·8 cites·15 claims
- 1630US6232080B1Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their useSCRIPPS RESEARCH INST·Filed 1998·Granted May 15, 2001·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Didier Leturcq files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →